Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2022 September Pharma News European commission approves CAR T-cell therapy brexucabtagene autoleucel for treatment ALL Read more
2022 June Pharma News Fast track designation to Prothera’s mocravimod for AML patients receiving HSCT Read more
2022 May Pharma News RMAT designation to obecabatagene autoleucel by FDA for patients with acute lymphoblastic leuk... Read more
2022 January Covid-19 Covid-19 vaccines show reduced efficacy in patients with multiple myeloma Read more
2021 December Medical Research Next generation sequencing assay for clonality detection in classic Hodgkin lymphoma Read more
2021 June Pharma News First CAR-T cell therapy to treat adult patients with R/R multiple myeloma Read more
Top
